According to the latest report by IMARC Group, titled "Computational Biology Market Report by Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), Services (In-House, Contract), End Use (Academics, Pharmaceutical Industry, Commercial), and Region 2025-2033," the global computational biology market reached a value of USD 6.8 Billion in 2024. Computational biology refers to a branch of biology that involves the application of computer science to study the processes of life. It involves the utilization of various computational methods for the simulation and representation of biological systems on a large scale. Some of the popular adopted methods include algorithms, machine learning (ML), statistical physics, robotics and complexity theory that aid in determining the cellular function and treatment for multiple diseases. As a result, it is extensively used for examining atomic information, such as three-dimensional (3D) protein structure, bio-sequences of DNA, RNA and protein, and gene expression data.
Global Computational Biology Market Trends:
The global market is primarily driven by the increasing demand for medical drugs. This is supported by the escalating prevalence of chronic diseases due to the sedentary lifestyles led by the masses. Along with this, the rising funding for conducting extensive research and development (R&D) activities to introduce effective and safe therapeutic products that aid in the treatment of acute illnesses is creating a positive market outlook. In line with this, the recent outbreak of coronavirus disease (COVID-19) has further propelled the demand for computational biology worldwide. Additionally, continuous technological advancements, such as the widespread adoption of artificial intelligence (AI) in modern computational biology for predicting the molecular behavior of medical drugs, are favorably impacting the market. Furthermore, the increasing investments by private and public agencies to upgrade the existing healthcare infrastructure is acting as another major growth-inducing factor. Other factors, including the augmenting preference for clinical studies and a considerable rise in the number of research centers, laboratories and educational institutes, are also strengthening the market growth. Looking forward, the market value is projected to reach USD 32.2 Billion by 2033, expanding at a CAGR of 17.83% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Application, Services, End Use, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systèmes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrödinger Inc. and Simulations Plus Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal